Liver transplantation for advanced hepatocellular carcinoma

Research output: Contribution to journalReview articleResearchpeer-review

17 Citations (Scopus)

Abstract

There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.

Original languageEnglish
Pages (from-to)309-318
Number of pages10
JournalClinical and Molecular Hepatology
Volume22
Issue number3
DOIs
StatePublished - 1 Jan 2016

Fingerprint

Liver Transplantation
Hepatocellular Carcinoma
Living Donors
Biomarkers
Tissue Donors
Patient Selection
Neoplasms
Transplants
Recurrence
Survival
Liver

Keywords

  • Biomarker
  • Carcinoma
  • Expanded criteria
  • Hepatocellular
  • Liver
  • Selection Criteria
  • Transplantation

Cite this

@article{6ce89d6db12e487e8115ccd624a70782,
title = "Liver transplantation for advanced hepatocellular carcinoma",
abstract = "There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.",
keywords = "Biomarker, Carcinoma, Expanded criteria, Hepatocellular, Liver, Selection Criteria, Transplantation",
author = "Lee, {Hae Won} and Kyungsuk Suh",
year = "2016",
month = "1",
day = "1",
doi = "10.3350/cmh.2016.0042",
language = "English",
volume = "22",
pages = "309--318",
journal = "Clinical and molecular hepatology",
issn = "2287-2728",
publisher = "Korean Association for the Study of the Liver",
number = "3",

}

Liver transplantation for advanced hepatocellular carcinoma. / Lee, Hae Won; Suh, Kyungsuk.

In: Clinical and Molecular Hepatology, Vol. 22, No. 3, 01.01.2016, p. 309-318.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Liver transplantation for advanced hepatocellular carcinoma

AU - Lee, Hae Won

AU - Suh, Kyungsuk

PY - 2016/1/1

Y1 - 2016/1/1

N2 - There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.

AB - There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded. Based on this idea, various studies have been conducted to further expand the Milan criteria and give more HCC patients a chance of cure. In deceased donor LT (DDLT) setting, expansion of the criteria is relatively tempered because the results of LT for HCC should be comparable to those of patients with non-malignant indications. On the other hand, in living donor LT (LDLT) situation, liver grafts are not public resources. The acceptable target outcomes for LDLT might be much lower than those for DDLT. Patients with biologically favorable tumors might have excellent survivals after LT despite morphological advanced HCCs. Therefore, the significance and utility of biological tumor parameters for selecting suitable LT candidates have been increased to predict HCC recurrence after LT. Although there is no consensus regarding the use of prognostic biomarkers in LT selection criteria for HCC, the combination of conventional morphological parameters and new promising biomarkers could help us refine and expand the LT criteria for HCC in the near future.

KW - Biomarker

KW - Carcinoma

KW - Expanded criteria

KW - Hepatocellular

KW - Liver

KW - Selection Criteria

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85014808340&partnerID=8YFLogxK

U2 - 10.3350/cmh.2016.0042

DO - 10.3350/cmh.2016.0042

M3 - Review article

VL - 22

SP - 309

EP - 318

JO - Clinical and molecular hepatology

JF - Clinical and molecular hepatology

SN - 2287-2728

IS - 3

ER -